VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 234 filers reported holding VERACYTE INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,176,755 | +301.8% | 142,264 | +358.3% | 0.00% | – |
| Q2 2023 | $790,665 | -73.5% | 31,043 | -76.8% | 0.00% | -100.0% |
| Q1 2023 | $2,988,423 | +3.2% | 134,010 | +9.8% | 0.00% | 0.0% |
| Q4 2022 | $2,895,131 | -11.6% | 122,003 | -38.2% | 0.00% | 0.0% |
| Q3 2022 | $3,275,000 | +129.2% | 197,309 | +174.8% | 0.00% | – |
| Q2 2022 | $1,429,000 | -43.6% | 71,794 | -21.9% | 0.00% | – |
| Q1 2022 | $2,535,000 | -69.0% | 91,960 | -53.7% | 0.00% | – |
| Q4 2021 | $8,188,000 | +145.7% | 198,740 | +177.0% | 0.00% | – |
| Q3 2021 | $3,333,000 | +10.4% | 71,736 | -5.0% | 0.00% | – |
| Q2 2021 | $3,019,000 | -31.1% | 75,497 | -7.4% | 0.00% | -100.0% |
| Q1 2021 | $4,381,000 | -64.8% | 81,521 | -67.9% | 0.00% | 0.0% |
| Q4 2020 | $12,450,000 | +658.2% | 254,348 | +403.3% | 0.00% | – |
| Q3 2020 | $1,642,000 | +13.2% | 50,541 | -9.8% | 0.00% | – |
| Q2 2020 | $1,450,000 | -36.9% | 56,006 | -40.8% | 0.00% | – |
| Q1 2020 | $2,299,000 | -14.1% | 94,570 | -1.3% | 0.00% | -100.0% |
| Q4 2019 | $2,677,000 | -18.1% | 95,854 | -29.6% | 0.00% | 0.0% |
| Q3 2019 | $3,270,000 | -60.6% | 136,242 | -53.2% | 0.00% | 0.0% |
| Q2 2019 | $8,294,000 | +300.3% | 290,906 | +251.3% | 0.00% | 0.0% |
| Q1 2019 | $2,072,000 | +930.8% | 82,800 | +419.3% | 0.00% | – |
| Q4 2018 | $201,000 | -5.2% | 15,946 | -28.2% | 0.00% | – |
| Q3 2018 | $212,000 | -21.8% | 22,200 | -54.5% | 0.00% | – |
| Q1 2018 | $271,000 | -35.2% | 48,754 | -23.8% | 0.00% | – |
| Q4 2017 | $418,000 | -60.3% | 64,000 | -46.6% | 0.00% | – |
| Q3 2017 | $1,052,000 | +39.3% | 119,893 | +32.4% | 0.00% | – |
| Q2 2017 | $755,000 | -9.6% | 90,586 | -0.4% | 0.00% | – |
| Q1 2017 | $835,000 | -26.3% | 90,937 | -37.9% | 0.00% | – |
| Q4 2016 | $1,133,000 | +99.8% | 146,429 | +96.6% | 0.00% | – |
| Q3 2016 | $567,000 | -24.5% | 74,493 | -50.1% | 0.00% | – |
| Q2 2016 | $751,000 | +2.9% | 149,207 | +10.5% | 0.00% | – |
| Q1 2016 | $730,000 | – | 135,044 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |